Immunophenotyping in pemphigus reveals a TH17/TFH17 cell–dominated immune response promoting desmoglein1/3-specific autoantibody productionJulia Holstein, Christian Möbs, Robert Pollmann et al.|Journal of Allergy and Clinical Immunology|2020Cited by 95
Safety, tolerability, pharmacokinetics and pharmacodynamic effects of desmoglein 3 peptide-coupled tolerizing nanoparticles in pemphigusDario Didona, Michael Hertl, Christoph Hudemann et al.|British Journal of Dermatology|2025Cited by 5